CureVac
↗Tübingen, Germany
CureVac is a clinical-stage biopharmaceutical company that pioneered the development of messenger RNA (mRNA) technology. Founded in 2000, the company leverages mRNA as a data carrier to instruct the human body to produce its own proteins to fight a wide range of diseases. Its proprietary platform focuses on optimized mRNA design, delivery systems, and large-scale manufacturing.
Following its acquisition by BioNTech in late 2025, CureVac now operates as a specialized subsidiary focused on advancing next-generation mRNA oncology immunotherapies and infectious disease vaccines. The company is known for its 'RNA Printer,' a mobile, automated production unit for rapid vaccine and therapy manufacturing.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:mRNA Therapeutics & Vaccines
SIZE & FINANCIALS
Employees:501-1000
Revenue:$50M-$100M
Founded:2000
Ownership:subsidiary
Status:acquired
FUNDING
Stage:Acquired
Total Raised:$1.7B
Investors:BioNTech, GSK, Dietmar Hopp (dievini Hopp BioTech holding), KfW (German Government), Bill & Melinda Gates Foundation
STOCK
Exchange:NASDAQ
Ticker:CVAC
Market Cap:$1.34B
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2 (Avian Flu / Glioblastoma)
Modalities:mRNA, LNP (Lipid Nanoparticles), Cancer Vaccines
Active Trials:8
Trial Phases:Phase 1: 5 | Phase 2: 3
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:BioNTech SE
Acquired By:BioNTech SE (2025-12-01)
Subsidiaries:CureVac Inc. (USA), CureVac Belgium SA, CureVac Netherlands B.V.
Key Partnerships:GSK (Infectious diseases license), MD Anderson Cancer Center (Oncology collaboration), CRISPR Therapeutics (Gene editing delivery)
COMPETITION
Position:Leader
Competitors:Moderna, BioNTech (Parent), Translate Bio (Sanofi), Arcturus Therapeutics
LEADERSHIP
Key Executives:
Alexander Zehnder - CEO (Pre-Acquisition)
Ugur Sahin - Board Member (Post-Acquisition)
Scientific Founders:Ingmar Hoerr, Florian von der Mülbe, Steve Pascolo
Board Members:Jean Stéphenne, Craig A. Tooman
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with CureVac. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.